X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (18) 18
immunology (17) 17
immunotherapy (17) 17
mice (17) 17
index medicus (16) 16
cancer (11) 11
mice, inbred c57bl (11) 11
t cells (11) 11
aging (10) 10
dendritic cells (10) 10
female (9) 9
humans (9) 9
macrophages (9) 9
mesothelioma (9) 9
cell biology (8) 8
tumors (8) 8
cell line, tumor (7) 7
flow cytometry (7) 7
oncology (7) 7
research (7) 7
age (6) 6
malignant mesothelioma (6) 6
mesothelioma - pathology (6) 6
aging - immunology (5) 5
antibodies (5) 5
chemotherapy (5) 5
expression (5) 5
geriatrics & gerontology (5) 5
inflammation (5) 5
lymphocytes t (5) 5
medicine (5) 5
mesothelioma - immunology (5) 5
responses (5) 5
rodents (5) 5
solid tumors (5) 5
t-lymphocytes - immunology (5) 5
aged (4) 4
aged mice (4) 4
analysis (4) 4
animal models (4) 4
cd40 antigens - immunology (4) 4
cd8 t-cells (4) 4
cd8-positive t-lymphocytes - immunology (4) 4
dendritic cells - immunology (4) 4
immunity (4) 4
interleukin-2 - administration & dosage (4) 4
lymph nodes (4) 4
macrophage (4) 4
mdx mice (4) 4
mesothelioma - drug therapy (4) 4
muscle, skeletal - metabolism (4) 4
original research (4) 4
pathology (4) 4
research article (4) 4
science (4) 4
vaccination (4) 4
antigens (3) 3
antigens, neoplasm - immunology (3) 3
apoptosis (3) 3
cd4 antigen (3) 3
cd4-positive t-lymphocytes - immunology (3) 3
cd40 antigen (3) 3
cd8 antigen (3) 3
cell proliferation (3) 3
cytokine gene-therapy (3) 3
cytokines (3) 3
differentiation (3) 3
disease models, animal (3) 3
gene expression (3) 3
genetic aspects (3) 3
health aspects (3) 3
il-2 (3) 3
immune response (3) 3
immune system (3) 3
immunohistochemistry (3) 3
immunosenescence (3) 3
interleukin 2 (3) 3
interleukin-2 (3) 3
interleukin-2 - immunology (3) 3
lipids (3) 3
lymphocytes (3) 3
macrophages - immunology (3) 3
medicine & public health (3) 3
mesothelioma - therapy (3) 3
multidisciplinary sciences (3) 3
muscular-dystrophy (3) 3
nemaline myopathy (3) 3
neoplasms - immunology (3) 3
t-cells (3) 3
t-lymphocytes - metabolism (3) 3
tumor immunity (3) 3
tumor microenvironment - immunology (3) 3
actin (2) 2
actins - genetics (2) 2
actins - metabolism (2) 2
ageing (2) 2
agonist anti-cd40 antibody (2) 2
antigen presentation - immunology (2) 2
antineoplastic agents - therapeutic use (2) 2
antitumor immunity (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Aging Cell, ISSN 1474-9718, 06/2013, Volume 12, Issue 3, pp. 345 - 357
Journal Article
International Immunology, ISSN 0953-8178, 11/2008, Volume 20, Issue 11, pp. 1467 - 1479
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 04/2012, Volume 61, Issue 4, p. 549
  Targeting interleukin-2 (IL-2) and/or agonist anti-CD40 antibody (Ab) into tumors represents an effective vaccination strategy that avoids systemic toxicity... 
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 04/2012, Volume 61, Issue 4, p. 549
Targeting interleukin-2 (IL-2) and/or agonist anti-CD40 antibody (Ab) into tumors represents an effective vaccination strategy that avoids systemic toxicity... 
Vaccination | Memory | Oncology, Experimental | Antibodies | Research | T cells | Cells | Viral antibodies | Interleukins | Analysis | Immunotherapy | Tumors | Cancer
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 04/2012, Volume 61, Issue 4, pp. 549 - 560
Targeting interleukin-2 (IL-2) and/or agonist anti-CD40 antibody (Ab) into tumors represents an effective vaccination strategy that avoids systemic toxicity... 
Animal models | Immunological memory | Memory cells | CD40 antigen | CD8 antigen | Toxicity | Vaccination | Antibodies | Lymphocytes T | Lymph nodes | CD4 antigen | Cell activation | Interleukin 2 | CD44 antigen | Immunotherapy | Cell migration | Tumors
Journal Article
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 08/2013, Volume 8, Issue 8, p. e73684
Copper, an essential trace element acquired through nutrition, is an important co-factor for pro-angiogenic factors including vascular endothelial growth... 
PHASE-II TRIAL | INDUCED APOPTOSIS | MULTIDISCIPLINARY SCIENCES | CHELATING AGENT | ENDOTHELIAL-CELLS | LOWERING THERAPY | WILSONS-DISEASE | FIBROSARCOMA CELLS | D-PENICILLAMINE | MALIGNANT MESOTHELIOMA | CANCER-THERAPY | Mesothelioma - immunology | Mesothelioma - pathology | Endothelial Cells - metabolism | Humans | Ki-67 Antigen - metabolism | Chelating Agents - pharmacology | Neoplasm Proteins - metabolism | Mesothelioma - drug therapy | Neovascularization, Pathologic - pathology | Endothelial Cells - immunology | Intercellular Adhesion Molecule-1 - metabolism | Animals | Mesothelioma - metabolism | T-Lymphocytes - metabolism | Neovascularization, Pathologic - drug therapy | Copper - metabolism | Female | T-Lymphocytes - immunology | Cell Proliferation - drug effects | Mice | Neovascularization, Pathologic - immunology | Neovascularization, Pathologic - metabolism | T-Lymphocytes - pathology | Endothelial Cells - pathology | Growth | Statistics | Vascular endothelial growth factor | Tumors | Cell proliferation | Flow cytometry | Asbestos | Atomic absorption analysis | Brain cancer | Antibodies | Mesothelioma | Confocal microscopy | Lymphocytes T | Confocal | Tissues | Cancer therapies | Metastases | Angiogenesis | Cell activation | Cell growth | Immunology | Developmental stages | Lymphocytes | Rodents | Atomic absorption spectrophotometry | Immunotherapy | Penicillin | Cell cycle | Copper | Nutrition | Organs | Blood vessels | Cures | Bioavailability | Metabolism | Cisplatin | Spectral analysis | Endothelial cells | CD4 antigen | Cytometry | Chemotherapy | Brain research | Microscopy | Medical prognosis | Trace elements | Infiltration | Chelating agents | Spectrophotometry | Cancer | Apoptosis
Journal Article
FRONTIERS IN GENETICS, ISSN 1664-8021, 11/2018, Volume 9, p. 526
Most cancers emerge in the elderly, including lung cancer and mesothelioma, yet the elderly remain an underrepresented population in pre-clinical cancer... 
ANALYSIS REVEALS | CANCER CACHEXIA | cachexia | macrophage | T cells | MESOTHELIAL CELLS | BREAST-CANCER | OLD MICE | NECROSIS-FACTOR | immunotherapy | HEMATOPOIETIC STEM-CELLS | IN-VIVO | GENETICS & HEREDITY | cancer | aging | MAGE-B | AGE | Prevention | Complications and side effects | Usage | Rats as laboratory animals | Immunotherapy | Cachexia | Research | Macrophages | Health aspects | Risk factors
Journal Article
Immunology and Cell Biology, ISSN 0818-9641, 02/2011, Volume 89, Issue 2, pp. 255 - 267
Targeting CD40, a member of the tumor necrosis factor superfamily, using agonist antibodies (Abs) produces dramatic antitumor effects. Indeed, high‐dose... 
tumor targeting | tumor immunity | B cells | cytotoxic T cells | agonist anti‐CD40 antibody | agonist anti-CD40 antibody | SOLID TUMORS | CYTOKINE GENE-THERAPY | IMMUNOLOGY | DRAINING LYMPH-NODES | CELL BIOLOGY | RESPONSES | CD40 ACTIVATION | IMMUNOLOGICAL ENHANCEMENT | HUMORAL IMMUNITY | DEPRIVED MICE | MALIGNANT MESOTHELIOMA | T-CELLS | Mesothelioma - immunology | Antibodies, Neoplasm - therapeutic use | Lymph Nodes - pathology | Mesothelioma - pathology | Dendritic Cells - immunology | Dendritic Cells - pathology | Immunoglobulin M - immunology | Lymphocyte Activation - immunology | Antibodies, Neoplasm - pharmacology | Immunoglobulin G - immunology | T-Lymphocytes - drug effects | Killer Cells, Natural - immunology | Dendritic Cells - drug effects | Lymph Nodes - drug effects | Tumor Microenvironment - drug effects | Antigens, Neoplasm - immunology | CD40 Antigens - agonists | Lymph Nodes - immunology | Antigen Presentation - immunology | Remission Induction | Mesothelioma - drug therapy | Tumor Microenvironment - immunology | B-Lymphocytes - drug effects | Animals | B-Lymphocytes - immunology | Mesothelioma - blood | Lymphocyte Activation - drug effects | Autoantigens - immunology | T-Lymphocytes - immunology | Antigen Presentation - drug effects | Cell Proliferation - drug effects | Mice | CD40 Antigens - immunology
Journal Article